UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.48B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$690M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$588M |
| 4 |
Truist Financial
TFC
|
+$532M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3B |
| 2 |
Alibaba
BABA
|
+$771M |
| 3 |
AABA
Altaba Inc
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.82% |
| 2 | Financials | 7.38% |
| 3 | Healthcare | 6.65% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Comscore
SCOR
$109M
| $2.95M | ﹤0.01% |
29,847
+1,208
| +4% | +$82.6K |
|
|
FIF
3152
DELISTED
FIRST TRUST ENERGY INFRASTRUCTURE FUND
FIF
| $2.95M | ﹤0.01% |
175,205
-955
| -0.5% | -$15.2K |
|
3153
PUT
APA Corp
APA
$13.2B
| $2.95M | ﹤0.01% |
+115,200
| New | +$2.61M |
|
|
NFO
3154
DELISTED
Invesco Insider Sentiment ETF
NFO
| $2.95M | ﹤0.01% |
40,822
-15,956
| -28% | -$1.13M |
|
3155
CVB Financial
CVBF
$3.99B
| $2.95M | ﹤0.01% |
136,525
-25,304
| -16% | -$536K |
|
|
ATCO
3156
DELISTED
Atlas Corp.
ATCO
| $2.95M | ﹤0.01% |
207,277
+93,059
| +81% | +$1.11M |
|
|
DBD
3157
DELISTED
Diebold Nixdorf Incorporated
DBD
| $2.94M | ﹤0.01% |
278,625
+66,034
| +31% | +$586K |
|
3158
PUT
American Eagle Outfitters
AEO
$3.01B
| $2.94M | ﹤0.01% |
+200,000
| New | +$3.05M |
|
3159
CALL
Envista
NVST
$4.52B
| $2.94M | ﹤0.01% |
+99,200
| New | +$2.82M |
|
3160
Antero Midstream
AM
$10.1B
| $2.94M | ﹤0.01% |
387,208
-483,483
| -56% | -$3.06M |
|
|
STL
3161
DELISTED
Sterling Bancorp
STL
| $2.93M | ﹤0.01% |
138,980
+11,388
| +9% | +$232K |
|
3162
AXIS Capital
AXS
$7.55B
| $2.92M | ﹤0.01% |
49,198
-68,208
| -58% | -$4.13M |
|
3163
iShares MSCI Emerging Markets Asia ETF
EEMA
$860M
| $2.92M | ﹤0.01% |
41,299
-1,360
| -3% | -$91.4K |
|
|
AIMC
3164
DELISTED
Altra Industrial Motion Corp
AIMC
| $2.92M | ﹤0.01% |
80,617
+28,486
| +55% | +$905K |
|
|
FOLD
3165
DELISTED
Amicus Therapeutics
FOLD
| $2.92M | ﹤0.01% |
299,438
-556,404
| -65% | -$5.09M |
|
3166
Nuveen Preferred & Income Opportunities Fund
JPC
$2.9B
| $2.92M | ﹤0.01% |
278,733
-18,413
| -6% | -$187K |
|
3167
Range Resources
RRC
$8.95B
| $2.91M | ﹤0.01% |
600,737
-49,414
| -8% | -$199K |
|
3168
CALL
ResMed
RMD
$30.7B
| $2.91M | ﹤0.01% |
18,750
-1,750
| -9% | -$252K |
|
3169
Allison Transmission
ALSN
$9.82B
| $2.9M | ﹤0.01% |
60,079
-13,060
| -18% | -$607K |
|
3170
BlackRock Income Trust
BKT
$341M
| $2.9M | ﹤0.01% |
159,807
+14,210
| +10% | +$259K |
|
3171
QuidelOrtho
QDEL
$838M
| $2.89M | ﹤0.01% |
38,517
+2,788
| +8% | +$180K |
|
3172
Allegiant Air
ALGT
$2.57B
| $2.89M | ﹤0.01% |
16,598
+3,916
| +31% | +$648K |
|
3173
Editas Medicine
EDIT
$442M
| $2.88M | ﹤0.01% |
97,435
-140,570
| -59% | -$3.51M |
|
3174
Equifax
EFX
$21.4B
| $2.88M | ﹤0.01% |
20,577
-33,863
| -62% | -$4.69M |
|
3175
WSFS Financial
WSFS
$4.15B
| $2.88M | ﹤0.01% |
65,513
+19,202
| +41% | +$839K |
|
Similar funds
UBS Group's Q4 2019 Portfolio in Review
As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
- UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
- UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
- UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
- UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
- UBS Group opened 808 new positions and closed 688 in Q4 2019.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.